Evidence map›Paper›PMID 40329355›Full record

ArticleChinese medicine2025

Gut microbiota-based bioassay for the quality evaluation of different species of Dendrobium and their therapeutic potential in type 2 diabetes.

Junju Zou, Qianbo Song, David Tai Wai Lau, Pang Chui Shaw, Zhong Zuo

Abstract read
In one paragraph

Article in Chinese medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Junju Zou *Guangdong-Hong Kong-Macao New Drug Screening Joint Laboratory, School of Pharmacy, Faculty of Medicine, The Chinese University of Hong Kong, Shatin, N.T., Hong Kong SAR, China.
Qianbo Song *Guangdong-Hong Kong-Macao New Drug Screening Joint Laboratory, School of Pharmacy, Faculty of Medicine, The Chinese University of Hong Kong, Shatin, N.T., Hong Kong SAR, China.
David Tai Wai LauLi Dak Sum Yip Yio Chin R & D Center for Chinese Medicine and School of Life Sciences, The Chinese University of Hong Kong, Shatin, Hong Kong SAR, China.
Pang Chui ShawLi Dak Sum Yip Yio Chin R & D Center for Chinese Medicine and School of Life Sciences, The Chinese University of Hong Kong, Shatin, Hong Kong SAR, China.
Zhong ZuoGuangdong-Hong Kong-Macao New Drug Screening Joint Laboratory, School of Pharmacy, Faculty of Medicine, The Chinese University of Hong Kong, Shatin, N.T., Hong Kong SAR, China. joanzuo@cuhk.edu.hk.

Funding

China Postdoctoral Science Foundation 2021M701180General Projects of Hunan Provincial Administration of Traditional Chinese Medicine B2023013Hong Kong Scholar program XJ2022048The science and technology innovation Program of Hunan Province 2023RC3165
6 · The paper itself

Abstract

backgroundDendrobium (DEN) have been utilized as valuable medicinal resource in China used for millennia for prevention and treatment of various diseases, particularly diabetes via alteration of their disordered gut microbiota. PURPOSE: The current study aimed to differentiate the quality of different species of DEN via an in vitro system including gut microbiota fermentation followed by antioxidative and hypoglycemic bioassays. MATERIAL AND

methodsAbout 100 g fresh DEN from four species (DEN-5 ~ DEN-8) was extracted with 1L boiling water twice with 1 h each time followed by centrifugation to obtain the supernatants as DEN aqueous extract. About 10 mg/mL of each DEN aqueous extract was fermented with fecal fluid from db/db mice for 12, 24 and 48 h, followed by monitoring the changes in total polysaccharide and polyphenol contents, antioxidative, hypoglycemic activities. Additionally, the level of short chain fatty acids and the abundance/diversity of gut microbiota in the DEN fermentation mixture were monitored via GC/MS and 16S rRNA, respectively. Moreover, in vivo hypoglycemic activities of DEN-5 ~ DEN-8 at the dosage of 200 mg/kg once daily for 14 days were also evaluated in db/db mice.

resultsDEN-5 ~ 8 varied in the content of polysaccharides (0.23-0.61, w/w) and polyphenol (0.008-0.023, w/w). Based on the free radical scavenging percentage, DEN antioxidative activities ranked as DEN-7≈DEN-8 > DEN-5 ≈DEN-6. Based on the percentage of enzyme inhibition, DEN antihyperglycemic activities ranked as DEN-5≈DEN-6 > DEN-8 > DEN-7. Hypoglycemic activities of DEN-5 ~ 8 in db/db mice were in the order of DEN-5≈DEN-6 > DEN-8 > DEN-7. Further correlation analyses of DEN polysaccharides content, DEN polyphenol content, SCFAs formation after in vitro fermentation, antioxidant activities, and hypoglycemic activities found that 1) polysaccharides contents in DEN-5 ~ 8 were positively correlate with total SCFAs generated after the fermentation, α-glucosidase inhibitory capacity, α-amylase inhibitory capacity, and GLP-1 level; 2) polyphenol contents in DEN-5 ~ 8 were positively correlate with ABTS, DPPH, and superoxide anion scavenging capacity.

conclusionsOur current study for the first time utilized a novel in vitro system to assess the hypoglycemic effects of different species of DEN and indicated that polysaccharides content in DEN was positively correlated with hypoglycemic effect while polyphenol content in DEN was positively correlated with antioxidant activity.

Indexed as

DendrobiumDiabetesGut microbiotaIn vitro fermentationShort chain fatty acids

Identifiers

PMID40329355
PMCPMC12053851

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.